KEGG   DRUG: Eptacog alfa
Entry
D00172                      Drug                                   

Name
Eptacog alfa (INN);
Eptacog alfa (activated) (genetical recombination) (JAN);
Coagulation Factor VIIa;
Coagulation factor VIIa (recombinant)-jncw;
Novo- seven (TN);
Sevenfact (TN)
Product
Formula
C1982H3054N560O618S28
Exact mass
45483.6943
Mol weight
45512.6574
Class
Cardiovascular agent
 DG02016  Hemostatics
  DG02013  Blood coagulation factor
  DG02014  Blood coagulation accelerant
   DG02013  Blood coagulation factor
Remark
Therapeutic category: 6349
ATC code: B02BD05 B02BD08
Chemical structure group: DG00172
Product (DG00172): D00172<JP/US>
Efficacy
Bleeding suppressant, Replenisher (coagulation factor)
Comment
human FVIIa [HSA:2155] [KO:K01320] analog
See F3 [HSA:2152] [KO:K03901]
See F10 [HSA:2159] [KO:K01314]
Interaction
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 B BLOOD AND BLOOD FORMING ORGANS
  B02 ANTIHEMORRHAGICS
   B02B VITAMIN K AND OTHER HEMOSTATICS
    B02BD Blood coagulation factors
     B02BD05 Coagulation factor VII
      D00172  Eptacog alfa (INN) <JP/US>
     B02BD08 Coagulation factor VIIa
      D00172  Eptacog alfa (INN) <JP/US>
Therapeutic category of drugs in Japan [BR:br08301]
 6  Agents against pathologic organisms and parasites
  63  Biological preparations
   634  Human blood preparations
    6349  Others
     D00172  Eptacog alfa (INN); Eptacog alfa (activated) (genetical recombination) (JAN)
New drug approvals in the USA [br08319.html]
 Cellular and gene therapy products
  D00172
New drug approvals in Europe [br08329.html]
 European public assessment reports (EPAR) authorised medicine
  D00172
New drug approvals in Japan [br08318.html]
 Drugs with new active ingredients
  D00172
New drug approvals in the USA, Europe and Japan [br08328.html]
 Approval dates by FDA, EMA and PMDA
  D00172
Other DBs
CAS: 102786-61-8
PubChem: 7847240
ChEBI: 3777
DrugBank: DB00036
LinkDB

» Japanese version   » Back

DBGET integrated database retrieval system